NASDAQ: COEPCoeptis Therapeutics Holdings Inc Stock Ownership - Who owns Coeptis Therapeutics Holdings?
Insider buying vs selling
Have Coeptis Therapeutics Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Chris Calise | Director | 2026-02-11 | 5,700 | $10.56 | $60.19kBuy |
| Christopher P. Cochran | Director | 2026-02-11 | 5,700 | $10.56 | $60.19kBuy |
| Brian Cogley | Chief Financial Officer | 2026-02-11 | 10,000 | $10.56 | $105.60kBuy |
| Philippe Deschamps | Director | 2026-02-11 | 5,700 | $10.56 | $60.19kBuy |
| Tara Desilva | Director | 2026-02-11 | 5,700 | $10.56 | $60.19kBuy |
| David Mehalick | CEO and President | 2026-02-11 | 148,875 | $7.05 | $1.05MBuy |
| Gene Salkind | Director | 2026-02-11 | 5,700 | $10.56 | $60.19kBuy |
| Christine Elise Sheehy | VP Compliance and Secy | 2026-02-11 | 1,000 | $10.56 | $10.56kBuy |
| Daniel Alexander Yerace | VP Operations | 2026-02-11 | 10,000 | $10.41 | $104.10kBuy |
COEP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when COEP insiders and whales buy or sell their stock.
COEP Shareholders
What type of owners hold Coeptis Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Chris Calise | 42.02% | 2,243,741 | $27.01M | Insider |
| Robert Striar | 35.11% | 1,875,000 | $22.58M | Insider |
| Bull Horn Holdings Sponsor LLC | 35.11% | 1,875,000 | $22.58M | Insider |
| Barclays PLC | 18.35% | 979,975 | $11.80M | Insider |
| Glazer Capital LLC | 18.06% | 964,422 | $11.61M | Insider |
| Harraden Circle Investments LLC | 9.63% | 514,436 | $6.19M | Insider |
| Vanguard Group Inc | 6.36% | 339,486 | $4.09M | Institution |
| David Mehalick | 6.18% | 330,192 | $3.98M | Insider |
| Daniel Alexander Yerace | 1.32% | 70,531 | $849.19k | Insider |
| Christine Elise Sheehy | 1.20% | 64,031 | $770.93k | Insider |
COEP vs Biotech Stocks
Coeptis Therapeutics Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.